coagulation factor Xa (recombinant), inactivated-zhzo 200 MG Injection [Andexxa]

RxNorm concept 2108130, branded drug (sbd). Prescribable name: ANDEXXA 200 MG Injection.

RxCUI: 2108130
Term type: Branded drug (SBD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/2108130 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

andexanet alfa 2045114

Other names

Andexxa 200 MG Injection

Related concepts

coagulation factor Xa (recombinant), inactivated-zhzo 200 MG (SCDC, consists of)
coagulation factor Xa (recombinant), inactivated-zhzo 200 MG [Andexxa] (SBDC, consists of)
Injection (DF, has dose form)
Andexxa (BN, has ingredient)
coagulation factor Xa (recombinant), inactivated-zhzo 200 MG Injection (SCD, tradename of)

Linked data

NDCs

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 2108130 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/2108130 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 2108130. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.